Catalyst Wire Dossier Catalyst Wire Dossier

GSK134612

Meningococcal vaccine · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for GSK134612, covering 2012-05-22 to 2019-08-06. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK134612 [Phase 3]

See pricing